Lipid metabolism was studied in three cystic fibrosis (CF) patients (18 years old) and three healthy controls (35-40 years old) who completed the New York Marathon 1984. Lipase was not detectable in plasma from two of the CF patients, but in one CF patient with a functioning pancreas and in the three controls it increased during and after the run. Cholesterol concentrations were lower in all patients than in the controls. The HDL/total cholesterol ratios increased in all runners throughout the observation period, substantially more in the patients than in the controls. Triglycerides and glycerol values were similar in the two groups. The relative distribution of fatty acids in total plasma, plasma free fatty acid fractions, and total red blood cell membranes, at rest, were similar to those earlier reported both for the CF patients with pancreatic insufficiency and for the controls. Lower relative concentrations of linoleic acid (C18:2n6) and higher relative concentrations of C14:0, C16:0, C16:1, C18:3n6, and C20:3n6 were found in the CF specimens. During and after the race, linoleic acid concentration increased and the other fatty acids decreased, giving a more normalized pattern in the patients. The fatty acid pattern of the CF patient with a functioning pancreas behaved more like the healthy controls. The fatty acid pattern of the red cell membrane did not change during or after the run. Although the observations are few, it is encouraging that both the HDL/total cholesterol ratio and the fatty acid pattern improve in response to prolonged aerobic exercise.

Download full-text PDF

Source
http://dx.doi.org/10.1055/s-2008-1025615DOI Listing

Publication Analysis

Top Keywords

fatty acid
16
fatty acids
12
acid pattern
12
cystic fibrosis
8
healthy controls
8
patient functioning
8
functioning pancreas
8
patients controls
8
hdl/total cholesterol
8
relative concentrations
8

Similar Publications

Gut Microbiota and Diabetes: Pioneering New Treatment Frontiers.

Endocr Metab Immune Disord Drug Targets

January 2025

Department of Medical Laboratory Sciences, School of Allied Medical Sciences, Lovely Professional University, Panjab, 144001, India.

Diabetes Mellitus (DM) is a complex metabolic disorder characterized by chronic hyperglycemia and poses significant global health challenges. Conventional treatments, such as insulin therapy and lifestyle modifications, have shown limited efficacy in addressing the multifactorial nature of DM. Emerging evidence suggests that gut microbiota, a diverse community of microorganisms critical for metabolism and immune function, plays a pivotal role in metabolic health.

View Article and Find Full Text PDF

Berberine Improves Glucose and Lipid Metabolism in Obese Mice through the Reduction of IRE1/GSK-3β Axis-Mediated Inflammation.

Endocr Metab Immune Disord Drug Targets

January 2025

Department of Endocrinology, Jiangyin Hospital Affiliated to Nanjing University of Chinese Medicine, No. 130 Renmin Middle Road, Jiangyin City, Jiangsu Province, 214413, China.

Introduction: Berberine (BBR) has the characteristics of repressing hyperglycemia, obesity, and inflammation, as well as improving insulin resistance. However, the underlying mechanism remains to be fully understood. This study explores whether BBR regulates inositol requiring enzyme 1 (IRE1)/glycogen synthase kinase 3 beta (GSK-3β) axis to resist obesity-associated inflammation, thereby improving glucolipid metabolism disorders.

View Article and Find Full Text PDF

Fecal microbiota transplantation (FMT) could significantly alter the recipient's gut bacteria composition and attenuate obesity and obesity-related metabolic syndromes. DL-norvaline is a nonproteinogenic amino acid and possesses anti-obesity potential. However, the specific mechanisms by which gut microbiota might mediate beneficial effects of DL-norvaline have not been completely elucidated.

View Article and Find Full Text PDF

Lipid droplets (LDs) are the major sites of lipid and energy homeostasis. However, few LD biogenesis proteins have been identified. Using model microalga , we show that ABHD1, an α/β-hydrolase domain-containing protein, is localized to the LD surface and stimulates LD formation through two actions: one enzymatic and one structural.

View Article and Find Full Text PDF

Background And Aims: Chronic fatigue is common in patients with inflammatory bowel disease (IBD). The gut microbiota, specifically, microbial diversity and butyrate-producing bacteria have been linked to the fatigue pathogenesis. High-dose oral thiamine reduces fatigue, potentially through gut microbiota modification.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!